Could treatment with R-HCVAD/R-MA as compared to R- CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma? - Response to Landsburg et al

Br J Haematol. 2014 Apr;165(1):146-7. doi: 10.1111/bjh.12704. Epub 2013 Dec 16.
No abstract available

Keywords: chemotherapy; lymphoma; non-Hodgkin lymphoma.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Male